The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Diamox Powder for Solution for Injection 500 mg/vial



Amdipharm LimitedPA1142/020/002

Main Information

Trade NameDiamox Powder for Solution for Injection 500 mg/vial
Active SubstancesACETAZOLAMIDE SODIUM
Dosage FormPowder for solution for injection
Licence HolderAmdipharm Limited
Licence NumberPA1142/020/002

Group Information

ATC CodeS01EC Carbonic anhydrase inhibitors
S01EC01 acetazolamide

Status

Authorised/WithdrawnAuthorised
Licence Issued01/04/1978
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back